Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/100133
DC FieldValueLanguage
dc.contributor.authorDiogo, Patrícia-
dc.contributor.authorCorreia, Gil-
dc.contributor.authorMartins, João B.-
dc.contributor.authorSoares, Rui-
dc.contributor.authorPalma, Paulo J.-
dc.contributor.authorSantos, João Miguel-
dc.contributor.authorGonçalves, Teresa-
dc.date.accessioned2022-05-16T08:23:46Z-
dc.date.available2022-05-16T08:23:46Z-
dc.date.issued2022-04-13-
dc.identifier.issn2076-393Xpt
dc.identifier.urihttps://hdl.handle.net/10316/100133-
dc.description.abstractThe ChAdOx1 nCoV-19 vector vaccine (Vaxzevria, AstraZeneca, Cambridge, UK) was developed at Oxford University and is considered safe for the administration in lactating mothers. Nevertheless, as a novel vaccine, there are gaps in the knowledge regarding possible adverse events in breastfeeding infants of vaccinated mothers. This case report provides first-time data on a possible delayed, cutaneous, adverse reaction in a breastfed, 16-month-old female infant after the first administration of the AstraZeneca vaccine to her 33-year-old mother. Even though, no clinical adverse effects were observed in the mother, her daughter had a 2-day rash in the lower extremities and face. The infant's cutaneous rashes might be a coincidental event. However, all skin lesions were analogous to previous descriptions and photographs of dermatologic reactions, which resolved spontaneously with no medical intervention, in people who had been vaccinated with other COVID-19 vaccines. Our aim is that this short report contributes to the enhancement of parental awareness about the possibility of similar skin rashes in breastfed children when the mothers receive a vaccination and the importance of reporting those adverse reactions to the competent authorities.pt
dc.language.isoengpt
dc.publisherMDPIpt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectAstraZenecapt
dc.subjectCOVID-19 vaccinespt
dc.subjectbreastfeedingpt
dc.subjectcutaneous reactionpt
dc.subjectlactationpt
dc.titleDelayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?pt
dc.typearticle-
degois.publication.firstPage602pt
degois.publication.issue4pt
degois.publication.titleVaccinespt
dc.peerreviewedyespt
dc.identifier.doi10.3390/vaccines10040602pt
degois.publication.volume10pt
dc.date.embargo2022-04-13*
uc.date.periodoEmbargo0pt
item.languageiso639-1en-
item.openairetypearticle-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
item.cerifentitytypePublications-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0002-3473-5801-
crisitem.author.orcid0000-0003-4730-8072-
crisitem.author.orcid0000-0001-9347-0535-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
I&D CNC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
vaccines-10-00602.pdf740.09 kBAdobe PDFView/Open
Show simple item record

SCOPUSTM   
Citations

1
checked on May 27, 2024

WEB OF SCIENCETM
Citations

1
checked on May 2, 2024

Page view(s)

119
checked on May 28, 2024

Download(s)

49
checked on May 28, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons